September 2026 legitimacy check · six verifiable facts, each dated · not a review score

Is Trimi Legit for Compounded Tirzepatide? Prices, Policies and the Money-Back Promise, Checked (September 2026)

Published: Updated: Provider pricing verified:

Trimi's $125-a-month annual plan is the second-lowest twelve-month total on a public page in the United States, and it is the only cheap program that promises money back. Here is what its documents say and where the conditions are.

By Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD · Published September 9, 2026 · Last reviewed September 9, 2026 · Sources cited at the end.

Editorial independence & affiliate disclosure: TirzepatideReview.com is affiliate-supported. That relationship cannot buy a ranking: positions follow the v4.1 methodology, and where a competitor publishes a lower verified price we show it.

Direct answer

Trimi passes the checks we can run from its public pages: a full price ladder is printed with totals ($235 monthly; $597 per quarter, $199/mo; $1,050 per six months, $175/mo; $1,500 per year, $125/mo — read September 9, 2026), the refund policy is dated (June 17, 2026), the money-back promise is stated with its condition on the treatment page (“Follow your plan for 6 months and if you don’t lose weight, you can request a refund. Terms apply.”), the promotion is a code (50OFF, $50 off a first month) rather than a struck-through list price, and the medical operation is described as physician-led (Arora Health; Dr. Sean Arora, MD, named on the site when we read it September 5). What we could not verify on this date: the LegitScript entry, the state licences of the dispensing pharmacies, and how “case by case” annual-plan exits are decided. No laboratory review is advertised. Compounded tirzepatide is not FDA-approved.

What “legit” means on this site

We do not grade a provider “legit” on reviews or star ratings. We check six things a patient can verify: (1) a named legal operator with an address in the terms; (2) named, licensed prescribers or a named prescriber network; (3) named dispensing pharmacies you can look up with a state board of pharmacy; (4) a price printed on the public page with its term; (5) a refund and cancellation policy with a date; (6) accurate regulatory language — compounded GLP-1s are not FDA-approved and a pharmacy is not “FDA-approved” either. The table shows which of the six we could verify, on which date, and which we could not.

Trimi, six legitimacy checks; documents read September 5, 2026, prices and promo September 9, 2026.
CheckWhat we foundVerified?Date
Legal operator / clinical entityPhysician-led; Arora Health and Dr. Sean Arora, MD named on the siteNamed; corporate registry not pulledSept 5, 2026
PrescribersBoard-certified clinician consultation included in every planStated; individual licences not checkedSept 9, 2026
PharmaciesCold-chain shipping from partner pharmacies; names as listed on the site when readNot re-checked Sept 9; licences not checked by usSept 5, 2026
Price on the page$235 monthly; $597 quarterly ($199/mo); $1,050 six-month ($175/mo); $1,500 annual ($125/mo); “same price at every prescribed dose”; no membership feeYesSept 9, 2026
Refund / cancellation policyDated June 17, 2026: money-back promise after a full continuous six months with logged weigh-ins, claim within 30 days; annual exits case by case; 100% refund if ineligibleYesSept 5, 2026
PromotionsCode 50OFF: $50 off the first month; $50 referral credit for both partiesYesSept 9, 2026
Regulatory languageCompounded medications described as not FDA-approvedAccurate on the pages we readSept 5, 2026
LegitScript certificationNot checked in the registry on this date
Laboratory review not stated on the plan pagesNot advertisedSept 9, 2026

Green flags and red flags

Where $125 sits

Twelve-month totals on a public page, read September 9, 2026.
Program12-month totalPer monthMonth-to-monthLabsRefund on the prepaid plan
Embody$1,428$119$129 (sale)Not advertisedNone (all payments final)
Trimi$1,500$125$235Not advertisedConditional 6-month promise; annual exit case by case
NexLife$1,668$139$169IncludedCancel-anytime subscription; warranty tied to 10% loss

Full review: Trimi Tirzepatide Review; the policies compared: the refund test; the break-even maths: month-to-month vs prepaid.

Medical and regulatory note: compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality; they are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational information, not medical advice. Consult a licensed clinician before starting, stopping or changing any medication, and confirm the price and prescribing requirements with the provider before enrolling.

Frequently asked questions

Is Trimi a legitimate provider? Trimi prints a full price ladder with totals, dates its refund policy (June 17, 2026), names a physician-led clinical operation and describes its compounded medications accurately as not FDA-approved (read September 5 and 9, 2026). We did not check the LegitScript registry or pharmacy licences on this date.

How much is Trimi's tirzepatide? $235 month to month; $597 per quarter ($199/mo); $1,050 per six months ($175/mo); $1,500 per year ($125/mo), read September 9, 2026. Code 50OFF takes $50 off a first month.

Does Trimi really give your money back? Its promise reads 'Follow your plan for 6 months and if you don't lose weight, you can request a refund. Terms apply.' The refund policy (June 17, 2026) requires a full continuous six months with logged weigh-ins and a claim within 30 days; annual-plan exits are case by case; a full refund applies if you are found ineligible.

Does Trimi include labs? Laboratory review is not advertised. Plans include the clinician consultation, dose management, messaging support, supplies and cold-chain shipping.

Is Trimi cheaper than NexLife? On a twelve-month total, yes: $1,500 vs $1,668 (read September 9, 2026). NexLife's plan includes laboratory review and is $169 month to month vs Trimi's $235.

Is compounded tirzepatide from Trimi FDA-approved? No. Compounded tirzepatide is not an FDA-approved product from any provider and is not reviewed by the FDA for safety, effectiveness or quality.

Recent changes to this page

September 9, 2026: Published.
Reviewed by Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD

Sources

  1. Trimi — compounded tirzepatide treatment page: prices, money-back promise (read 2026-09-09)
  2. Trimi — promo page: code 50OFF, referral credit, price ladders (read 2026-09-09)
  3. Trimi — Refund Policy, June 17, 2026 (read 2026-09-05)
  4. TirzepatideReview.com — open pricing dataset (JSON), snapshot 2026-09-09
  5. FDA — Human Drug Compounding: compounded drugs are not FDA-approved

Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician.